
Nasus Pharma Ltd. Share · IL0012181553 (XASE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Nasus Pharma Ltd.
No Price
Closing Price XASE 01.05.2026:
2,70 USD
01.05.2026 19:58
Current Prices from Nasus Pharma Ltd.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
AMEX |
NSRX
|
USD
|
01.05.2026 19:58
|
2,70 USD
| - |
Company Profile for Nasus Pharma Ltd. Share
Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. Their lead products include NS002, an intranasal powder epinephrine nasal spray for type 1 severe allergies and anaphylaxis, and NS001, an intranasal naloxone powder spray for opioid overdose. They use a powder-based intranasal technology that offers rapid drug absorption.
Company Data
Name Nasus Pharma Ltd.
Company Nasus Pharma Ltd.
Website
http://www.nasuspharma.com
Primary Exchange
AMEX
ISIN IL0012181553
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dan Teleman MBA
Market Capitalization 24 Mio
Country Israel
Currency USD
Employees 0,0 T
Address Yigal Alon 65, 6744317 Tel Aviv
IPO Date 2025-08-13
Ticker Symbols
| Name | Symbol |
|---|---|
| AMEX | NSRX |
More Shares
Investors who hold Nasus Pharma Ltd. also have the following shares in their portfolio:
